Medicine guide
Ozempic
1.5 mg · Tablet
- Prescription only
- GLP-1 Receptor Agonist
- Active substance
- Oral Semaglutide
- Made by
- Novo Nordisk Pharmaceutical Industries, LP
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Medicine groupDigestion, stomach, diabetes and nutrition
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | Novo Nordisk Pharmaceutical Industries, LP |
|---|---|
| Active substance | Oral Semaglutide |
| Used in | Digestion, stomach, diabetes and nutrition |
| Strength | 1.5 mg |
| Form | Tablet |
| Route | Oral |
| Packs | 30 TABLET in 1 BOTTLE, PLASTIC |
| NDC | 0169-1715 |
Source: NDC Directory · 2026-09-13 · not reviewed by a clinician
Source: US Food and Drug Administration, NDC Directory. Reuse terms: US government work (FDA).
Other strengths and forms
9 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- Injection, Solution6 products
.68 mg/mL2
.68 mg/mL · 2 companies
1.34 mg/mL2
1.34 mg/mL · 2 companies
2.68 mg/mL2
2.68 mg/mL · 2 companies
- Tablet3 products
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.
Ozempic4 mgPrescription only Novo Nordisk Pharmaceutical Industries, LP · Oral SemaglutideOzempic9 mgPrescription only Novo Nordisk Pharmaceutical Industries, LP · Oral SemaglutideRybelsus3 mgPrescription only Novo Nordisk Pharmaceutical Industries, LP · Oral SemaglutideRybelsus7 mgPrescription only Novo Nordisk Pharmaceutical Industries, LP · Oral SemaglutideRybelsus14 mgPrescription only Novo Nordisk Pharmaceutical Industries, LP · Oral Semaglutide